Pharma Manufacturing

Article

How India’s PLI scheme is rebuilding API manufacturing, strengthening supply chains, and reducing import dependence.

Vaibhavi M. | Dec 06, 2025

Article
Building KSM Manufacturing Clusters: Opportunities For SMEs In The Pharmaceutical Industry

Vaibhavi M. | Dec 06, 2025

Other trending pieces on pharma manufacturing you may like to read

Water stewardship in high risk zones: pharma’s call to action in 2026

Why water stewardship is critical for pharma manufacturing in 2026 and how it impacts global health, supply chains, and community resilience.

by Thaddeus Anim-Somuah
Pharma Now

From Generics Giant To Biologics Powerhouse: India’s Next Big Pharma Revolution

India is transitioning from generics dominance to a global biologics and biosimilars leader, shaping the future of advanced therapies.

by Simantini Singh Deo
Pharma Now

API Manufacturing Automation: How Robotics Are Reducing Risks In Hazardous Steps?

Automation and robotics are transforming API manufacturing with better safety, precision, and efficiency across hazardous steps.

by Simantini Singh Deo
Pharma Now

Production Linked Incentive (PLI) Schemes: Impact On The API Ecosystem In The Pharmaceutical Manufacturing Industry

India’s PLI scheme is rebuilding API manufacturing with local capacity, tech upgrades, and reduced import dependence.

by Vaibhavi M.
Pharma Now

Production Linked Incentive (PLI) Schemes: Impact On The API Ecosystem In The Pharmaceutical Manufacturing Industry

How India’s PLI scheme is rebuilding API manufacturing, strengthening supply chains, and reducing import dependence.

by Vaibhavi M.
Pharma Now